Latest news
Opus Genetics Reports Q2 2026 Results and Advances Multiple IRD Gene Therapy Programs with OPGx-BEST1 Data Expected in September - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMT